In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

Pittsburgh biotech startup InnSight Technology got a $1.3M Department of Defense grant to develop a biosensor for corneal injury detection.

Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...

For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...

What scientists long believed were knots in DNA may actually be persistent twists formed during nanopore analysis, revealing ...

OTO Fertility, a digital health platform developed by OTO Coach, is setting a new standard of care with patented biometric ...

WHO has prequalified two Covid-19 rapid antigen tests for the first time, confirming long-term quality and enabling UN ...

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027- Equity settlement mechanisms also ...